The Mediterranean diet has long held the crown as the gold standard for heart health. But here’s the thing: the version most of us think we know about might be missing some crucial ingredients. A landmark Spanish clinical trial just revealed that when you add three practical tweaks to the Mediterranean approach, you can cut your type 2 diabetes risk by nearly a third.
That’s not incremental improvement. That’s the kind of result that actually moves the needle on public health.
The PREDIMED-Plus trial, published in Annals of Internal Medicine, followed nearly 5,000 people over six years. The researchers weren’t trying to reinvent nutrition science. They were testing something simpler: what happens when you take the Mediterranean diet and pair it with calorie reduction, regular physical activity, and professional support for weight loss?
The results were striking. Participants who followed this structured approach lost significantly more weight, trimmed more abdominal fat, and dramatically lowered their diabetes risk compared to those who simply ate a traditional Mediterranean diet without guidance or structured changes.
The Three Things That Actually Made the Difference
Let’s be clear about what researchers are comparing here. One group followed a calorie-reduced Mediterranean diet (about 600 calories less per day), added moderate physical activity like brisk walking and strength training, and got professional guidance. The comparison group? They ate a traditional Mediterranean diet with zero restrictions and no exercise program.
The intervention group lost an average of 3.3 kilograms. The control group lost 0.6 kilograms. That’s not just better outcomes. That’s a fundamentally different trajectory.
Miguel Ruiz-Canela, the study’s first author and a professor at the University of Navarra, explained that “the Mediterranean diet acts synergistically to improve insulin sensitivity and reduce inflammation. With PREDIMED-Plus, we demonstrate that combining calorie control and physical activity enhances these benefits.”
The key word there is “synergistically.” It’s not that any single ingredient is revolutionary. It’s that they work together.
Why This Matters at Scale
Type 2 diabetes isn’t some rare condition affecting a small percentage of the population. More than 530 million people worldwide live with diabetes, according to the International Diabetes Federation. Spain alone has about 4.7 million adults with type 2 diabetes. Across Europe, the number climbs above 65 million.
The PREDIMED-Plus researchers estimated that their intervention prevented about three cases of type 2 diabetes for every 100 participants. That might sound modest on paper. Applied across populations at elevated risk globally, it could prevent thousands of new diagnoses annually.
This is especially relevant because experts warn that prevention is critical. Type 2 diabetes raises the risk of cardiovascular, kidney, and metabolic complications that cascade through a person’s health for decades.
The Real-World Catch
Here’s where the editorial accompanying the study, written by nutrition and public health experts at Temple University, gets blunt. They praised the clinical importance of PREDIMED-Plus but warned that transplanting this strategy to places outside the Mediterranean region—particularly the United States—would require more than individual willpower.
The barriers are real. Unequal access to healthy food, urban environments that make physical activity harder, and limited access to professional guidance all stand in the way. These aren’t individual failures. They’re systemic problems that require public policy solutions.
That’s an important reminder: a perfectly designed intervention doesn’t help much if the conditions around it make it nearly impossible to implement. The PREDIMED-Plus team worked through Spain’s National Health System in over 100 primary care centers, which meant infrastructure, support, and consistency. Try running that same program in a low-income neighborhood with minimal healthcare access, and the picture changes dramatically.
Beyond the Diabetes News
The PREDIMED-Plus work didn’t stop with diabetes findings. Related research has continued expanding the picture. A separate analysis published in JAMA Network Open found that the energy-reduced Mediterranean diet plus physical activity helped reduce total and visceral fat while slowing age-related loss of lean muscle mass in older adults with overweight and metabolic syndrome. That matters because visceral fat and declining muscle are closely tied to heart disease risk.
Recent work has also explored how sedentary time affects cardiovascular health. A 2026 study found that replacing sitting time with physical activity was associated with favorable changes in blood markers related to heart stress in people with metabolic syndrome.
The broader science on Mediterranean diet approaches continues to strengthen. A 2025 review in Cardiovascular Research described the Mediterranean diet as one of the best-studied dietary patterns for cardiovascular prevention, citing large randomized trials including the original PREDIMED and other major studies.
Interestingly, recent analysis from the original PREDIMED trial highlighted that food quality matters within the diet itself. Participants with higher cumulative intake of extra virgin olive oil had a lower cardiovascular risk, while common olive oil showed weaker associations. It’s a practical reminder that the Mediterranean diet isn’t just about eating less or eating more plants. The type and quality of fats you choose appears to matter.
The Medication Question
All of this is landing at a moment when obesity and diabetes drugs are attracting major attention and significant resources. GLP-1 agonists and similar medications have become household names. PREDIMED-Plus doesn’t argue that medication has no role. What it does argue is that medication isn’t the only path with genuine power.
“Applied at scale in at-risk populations, these modest and sustained lifestyle changes could prevent thousands of new diagnoses every year,” said Miguel Ángel Martínez-González, a principal investigator and professor at the University of Navarra. He added that the intervention is “a tasty, sustainable and culturally accepted approach that offers a practical and effective way to prevent type 2 diabetes—a global disease that is, to a large extent, avoidable.”
That last phrase is worth sitting with. Avoidable. Not incurable. Not inevitable. Avoidable.
What Makes This Different
The PREDIMED-Plus approach doesn’t rely on extreme dieting or cutting out entire food groups. It combines familiar foods, moderate activity, gradual weight loss, and professional support. Researchers say it could be used by primary care providers as a sustainable and cost-efficient prevention strategy.
This matters because so many prevention approaches feel impossible before you even start. This one doesn’t. It’s not trendy. It’s not extreme. It’s methodical, supported, and designed around foods and activities that people can actually stick with long-term.
The trial ran from 2013 to 2024, involved more than 200 researchers across 22 Spanish universities, hospitals, and research centers, and was funded by over 15 million euros in support from major Spanish research institutions and the European Research Council. It’s the kind of rigorous, large-scale work that doesn’t come around often.
So we have solid evidence that a structured Mediterranean approach works. We have clear identification of the three ingredients that make the difference: calorie reduction, physical activity, and professional support. And we have recognition that implementing this at scale requires addressing the structural barriers that make healthy choices difficult for many people.
The question now isn’t really whether this works. It’s whether we’re willing to build the systems that would allow it to work for everyone who needs it.
